Eton Pharmaceutical News

Eton Pharmaceutical | 8-K: Current report

Jun 12 04:23

Eton Pharmaceutical | 10-Q: Quarterly report

May 10 04:29

Eton Pharmaceutical | 8-K: Current report

May 10 04:23

Eton Pharmaceutical | 8-K: Current report

Apr 30 19:20

Eton Pharmaceutical | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Harrow, Inc.(0.0%)

Apr 30 19:05

Eton Pharmaceutical | DEF 14A: Definitive information statements

Apr 27 04:26

Eton Pharmaceutical | 8-K: Current report

Apr 19 04:27

Eton Pharmaceutical | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 27 04:25

Eton Pharmaceutical | 10-K/A: Annual report (Amendment)

Mar 23 04:27

Eton Pharmaceutical | 8-K: Current report

Mar 22 18:56

Eton Pharmaceutical | 10-K: Annual report

Mar 15 04:30

Eton Pharmaceutical | 8-K: Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 15 04:22

Eton Pharmaceutical | 8-K: Current report

Feb 21 20:00

Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Gruber James R.

Feb 16 05:25

Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer BRYNJELSEN SEAN

Feb 16 05:24

Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Adams Jennifer McKie

Feb 16 05:24

Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director CASAMENTO CHARLES J

Feb 16 05:23

Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director RIEDEL NORBERT G

Feb 16 05:19

Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director MAIER PAUL V

Feb 16 05:18

Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Krempa David

Feb 16 05:18